申请人:Ciba-Geigy Corporation
公开号:US05610178A1
公开(公告)日:1997-03-11
Compounds of the formula ##STR1## wherein R.sub.1 is hydroxy, 2-hydroxyethoxy, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkanoyloxy, halogen, amino, azido, a keto, p-nitrobenzenesulfonyl or a pyranyloxy group of the formula ##STR2## wherein X is a group of the formula ##STR3## wherein R.sub.3 is hydroxy, C.sub.1 -C.sub.4 alkanoyloxy or organic sulfonyloxy, and R.sub.4 is hydroxy or carbamoyloxy, R.sub.2 is hydrogen, hydroperoxy, hydroxy or methoxy, Y is a group of the formula ##STR4## wherein R.sub.5 is hydroxy or C.sub.1 -C.sub.4 alkanoyloxy, and R.sub.6 and R.sub.7 each independently of the other is hydrogen or methyl, are suitable for the preparation of a medicament for the prophylaxis and treatment of diseases that respond to the inhibition of the osteoclast proton pump.
式子为##STR1##的化合物,其中R.sub.1是羟基、2-羟基乙氧基、C.sub.1-C.sub.4烷氧基、C.sub.1-C.sub.4烷酰氧基、卤素、氨基、偶氮基、酮基、对硝基苯磺酰基或式子##STR2##中的吡喃氧基,其中X是式子##STR3##中的基团,其中R.sub.3是羟基、C.sub.1-C.sub.4烷酰氧基或有机磺酰氧基,R.sub.4是羟基或氨基甲酰氧基,R.sub.2是氢、过氧化氢、羟基或甲氧基,Y是式子##STR4##中的基团,其中R.sub.5是羟基或C.sub.1-C.sub.4烷酰氧基,R.sub.6和R.sub.7各自独立地是氢或甲基。这些化合物适用于制备用于预防和治疗对抑制骨吸收细胞质子泵反应的疾病的药物。